Pulmonx Corporation
LUNG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $265,564 | $484,176 | $312,724 | $1,158,670 |
| - Cash | $70,905 | $83,547 | $101,736 | $148,480 |
| + Debt | $56,471 | $41,424 | $24,402 | $26,460 |
| Enterprise Value | $251,130 | $442,053 | $235,390 | $1,036,650 |
| Revenue | $83,789 | $68,675 | $53,662 | $48,416 |
| % Growth | 22% | 28% | 10.8% | – |
| Gross Profit | $62,001 | $50,752 | $39,865 | $35,630 |
| % Margin | 74% | 73.9% | 74.3% | 73.6% |
| EBITDA | -$50,794 | -$55,092 | -$55,991 | -$46,622 |
| % Margin | -60.6% | -80.2% | -104.3% | -96.3% |
| Net Income | -$56,394 | -$60,843 | -$58,923 | -$48,661 |
| % Margin | -67.3% | -88.6% | -109.8% | -100.5% |
| EPS Diluted | -1.44 | -1.6 | -1.59 | -1.35 |
| % Growth | 10% | -0.6% | -17.8% | – |
| Operating Cash Flow | -$31,537 | -$37,610 | -$45,136 | -$41,429 |
| Capital Expenditures | -$1,447 | -$807 | -$1,318 | -$3,671 |
| Free Cash Flow | -$32,984 | -$38,417 | -$46,454 | -$45,100 |